Mowafy v. NORAMCO OF DELAWARE, INC.

620 F. Supp. 2d 603, 2009 U.S. Dist. LEXIS 46387, 2009 WL 1543902
CourtDistrict Court, D. Delaware
DecidedJune 2, 2009
DocketC.A. 05-733-JJF
StatusPublished
Cited by3 cases

This text of 620 F. Supp. 2d 603 (Mowafy v. NORAMCO OF DELAWARE, INC.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mowafy v. NORAMCO OF DELAWARE, INC., 620 F. Supp. 2d 603, 2009 U.S. Dist. LEXIS 46387, 2009 WL 1543902 (D. Del. 2009).

Opinion

MEMORANDUM OPINION

FARNAN, District Judge.

Pending before the Court is Defendant’s Motion For Summary Judgement (D.I. 50). For the reasons discussed, the Court will grant the Motion.

I. BACKGROUND

Plaintiff, Zahra Mowafy (“Mowafy”), is a fifty-seven year old Muslim woman. Defendants Noramco of Delaware, Inc. and Noramco, Inc.' (collectively, “Noramco”) are operating companies within the Johnson & Johnson Family of Companies that produce a variety of active ingredients in pharmaceutical compounds. (D.I. 52, Exh. A ¶ 6.) The relevant chronology of events is set forth below.

In May 2001, Mowafy applied for a position as a Senior Process Chemist with Noramco. (Id. ¶ 10.) Six Noramco employees interviewed her; three of the interviewers completed candidate evaluation forms and all three of them agreed that Noramco should pursue Mowafy’s candidacy further. (Id. at Exh. 1.) Two of the employees that filled out evaluation forms, Drs. Yong Zhang and Phil Cox, would later become Mowafy’s supervisors and, as set forth below, are implicated in Mowafy’s discrimination allegations.

Noramco subsequently offered Mowafy the position, and she began work in September 2001. (Id. ¶ 14.) At Noramco, Mowafy reported directly to Dr. Zhang, who, in turn, reported to Dr. Cox. (Id. ¶ 5.) The chemistry group at Noramco also included four student interns (“co-ops”) from Drexel University: Dan Markowitz, Lauren Franchetti, Jim Petner, and a fourth individual who remains unidentified in the briefing. Markowitz, Franchetti, and Petner figure heavily in Plaintiffs allegations of discrimination.

Indeed, Mowafy alleges a number of incidents involving the co-ops during her first few months of work. Mowafy alleges that during her first month of work, Markowitz and Franchetti repeatedly asked her about “Islam, its tenets, and why Muslims produce so many terrorists.” (D.I. 54 at A-l, A-24) During her second month of work, Franchetti is further alleged to have *608 screamed in fright upon observing Mowafy conducting her daily prayers in a bathroom, where Mowafy prayed for its privacy. (Id. at A-l.) Finally, Franchetti is, “[o]n some occasions,” alleged to have failed to inform Mowafy of lunch meetings with Dr. Cox, causing Plaintiff to arrive late to the lunch meetings. (Id.)

Shortly thereafter, during December of 2001, Markowitz and Petner are alleged to have “jerked a chair,” which caused Mowafy’s briefcase to fall, strewing her papers about the floor. (Id. at A-2.) In January 2001, the same two are further alleged to have urged Mowafy to open a file on her computer that resulted in the spread of virus, an act that they allegedly ridiculed and made fun of afterwards. (Id.) Also during this approximate time frame, Mowafy alleges that Markowitz made comments regarding Mowafy’s age. Specifically, Mowafy alleges that Markowitz responded to Mowafy’s requests for assistance with the comment “you can’t teach an old dog new tricks,” and remarked that Mowafy’s chapped hands were “an age related problem.” (Id.)

In January 2002, Mowafy received her first 90-day performance evaluation. Overall, she was rated as demonstrating “Effective Performance,” which is the middle category in Noramco’s five tier ranking system that included categories ranging from “Unsatisfactory Performance” to “Outstanding Performance.” Mowafy was given “Below Average” rankings in three particular categories pertaining to efficiency, regulatory compliance, and knowledge of industry skills and trends. (D.I. 52, Exh. A at Exh. 3.) On the other hand, she was given “Above Average” rankings in five particular categories pertaining to communication, initiative, and attentiveness. (Id.) For eight particular performance criteria, the reviewer provided no ranking, instead checking a box to indicate that it was too early to provide an evaluation. (Id.)

In March 2002 — only about six months after Plaintiff began work — Drs. Zhang and Cox held a meeting with Mowafy to discuss her performance. The substance of the meeting was detailed in a memorandum prepared the day after the meeting. (D.I. 52, Exh. A at Exh. 4.) The memorandum explained that Drs. Zhang and Cox “felt that [Plaintiffs] performance was not in line with that expected for a Senior Process Chemist.” (Id.) Specifically, the memo outlined slow performance toward the completion of a development plan and a high ratio of experiment failures. (Id.) The memorandum further noted a need for “better time management” and greater “focus on problem solving rather than unfocussed data gathering.” (Id.)

Mowafy alleges additional misconduct on the part of the co-ops in the time frame surrounding this performance meeting. Specifically, Mowafy complains of an incident when she spilled some alumina powder on her lab coat. This allegedly resulted in Petner accusing Mowafy of stealing narcotics. (D.I. 54 at A-26.) Petner is further alleged to have accused Mowafy of “bossing [him] around” and disconnecting one of his reactions. (D.I. 53 at 3^4.) Beginning in March 2002 and continuing to December 2002, Mowafy alleges that Dr. Zhang allowed the co-ops to arrive late, take long lunches, and leave early. (D.I. 54 at A-3, A-26.) In these circumstances, the co-ops are alleged to have openly bragged that Dr. Zhang would take their side in any dispute between them and Mowafy. (Id. at A-3.)

In July 2002, Dr. Zhang issued a lengthy written warning to Mowafy, explaining that Plaintiffs performance needed to improve. (D.I. 52, Exh. 4 at Exh. 5.) The warning detailed a “history of performance deficiencies,” including specific examples of *609 poor planning, slow performance, and failure to follow procedure. (Id.) For instance, the warning noted an instance where Mowafy had agreed to complete a series of four experiments to test a “critical parameter range.” According to the warning letter, the results of the first experiment could not be used “because the cooling profile used was not correct.” (Id.) Mowafy is then described as refusing to begin the next experiment, agreeing to do so only after a direct instruction from her supervisor. Ultimately, the warning letter explains, only two of the four experiments were completed on time. (Id.) The warning letter concluded by placing Mowafy on six months probation, instructing that any further performance incidents could result in termination. (Id.)

At roughly the same time, Mowafy received her mid-year performance evaluation. At this point, Mowafy was given an overall rating of “Below Average Performance.” (D.I. 52, Exh. 4 at Exh. 6.) With regard to particularized performance criteria, Mowafy received no “Above Average” ratings. Mowafy was rated as showing “Unsatisfactory Performance” in three categories, “Below Average Performance” in 16 categories, and “Effective Performance” in seven categories. (Id.) Mowafy reviewed the evaluation, noting in writing that she did not agree with the results. (Id.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pasquale v. KBR, Inc.
D. Delaware, 2024
Ashley v. Bayhealth Medical Center, Inc.
869 F. Supp. 2d 544 (D. Delaware, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
620 F. Supp. 2d 603, 2009 U.S. Dist. LEXIS 46387, 2009 WL 1543902, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mowafy-v-noramco-of-delaware-inc-ded-2009.